Cancer
TomoTherapy Users Highlight Hi-Art(R) Clinical Advantages at Investor Meeting
Published in Drug Week, April 11th, 2008
TomoTherapy Incorporated (NASDAQ: TOMO), maker of the Hi-Art(R) treatment system for advanced radiation therapy, held an investor meeting on March 13, 2008, at its headquarters in Madison, Wis. The event, arranged by investment firm William Blair & Company, included presentations from TomoTherapy's management team and two clinical experts in the field of radiation oncology: Patrick Kupelian, M.D., and Chet Ramsey, Ph.D.
Dr. Kupelian, director of clinical research for radiation oncology at MD Anderson Cancer Center Orlando, spoke on his early adoption of the Hi-Art treatment system and the center's recent decision to purchase a second Hi-Art unit.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2008-04-11)
More Articles from Drug Week
- Breast Cancer
Hormone replacement therapy increases breast cancer recurrence - Cord Blood
Umbilical cord blood cell therapy in an animal model of Alzheimer's disease - Depression
PTSD associated with more, longer hospitalizations - Drug Development
Pain receptor in brain may be linked to learning and memory - Drug Safety
FDA deadlines may compromise drug safety by rushing approval - Hypertension
Relaxation training may improve control of hard-to-treat systolic hypertension - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
